Mingyi Ju

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 6

Top Topics

Nlrp Inflammasome

Top Venues

Journal for immunotherapy of cancer

OncoTargets and therapy

Journal of cellular and molecular medicine

Briefings in bioinformatics

This page only lists publications with an associated author ORCID identifier.

Publications

Mingyi Ju, Jiaojiao Zhang, Zhuoyuan Deng, Minjie Wei, Lianghua Ma, Ting Chen, Lin Zhao
Prophylactic IL-23 blockade uncouples efficacy and toxicity in dual CTLA-4 and PD-1 immunotherapy. Journal for immunotherapy of cancer 12 (7) (2024)
Mingyi Ju, Jiaojiao Zhang, Zhuoyuan Deng, Minjie Wei, Lianghua Ma, Ting Chen, Lin Zhao
Prophylactic IL-23 blockade uncouples efficacy and toxicity in dual CTLA-4 and PD-1 immunotherapy. Journal for immunotherapy of cancer 12 (7) (2024)
Yunong Li, Mingyi Ju, Yuxi Miao, Lin Zhao, Lijuan Xing, Min-Jie Wei
Advancement of anti-LAG-3 in cancer therapy. FASEB journal : official publication of the Federation of American Societies for Experimental Biology 37 (11) (2023)
Mingyi Ju, Jia Bi, Qian Wei, Longyang Jiang, Qiutong Guan, Ming Zhang, Xinyue Song, Ting Chen, Jingyi Fan, Xiaojuan Li, Minjie Wei, Lin Zhao
Pan-cancer analysis of NLRP3 inflammasome with potential implications in prognosis and immunotherapy in human cancer. Briefings in bioinformatics 22 (4) (2021)
Mingyi Ju, Longyang Jiang, Qian Wei, Lifeng Yu, Lianze Chen, Yan Wang, Baohui Hu, Ping Qian, Ming Zhang, Chenyi Zhou, Zinan Li, Minjie Wei, Lin Zhao, Jiali Han
A Immune-Related Signature Associated with TME Can Serve as a Potential Biomarker for Survival and Sorafenib Resistance in Liver Cancer. OncoTargets and therapy 14 (2021)
Mingyi Ju, Aoshuang Qi, Jia Bi, Lan Zhao, Longyang Jiang, Qiang Zhang, Qian Wei, Qiutong Guan, Xueping Li, Lin Wang, Minjie Wei, Lin Zhao
A five-mRNA signature associated with post-translational modifications can better predict recurrence and survival in cervical cancer. Journal of cellular and molecular medicine 24 (11) (2020)